American Journal of Managed Care

The American Journal of Managed Care is a monthly medical journal that undergoes peer review and is released by Managed Care & Healthcare Communications, LLC. In 2009, it achieved an impact factor of 2.74.

International, National, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

#158986

United States

#47971

Health/Health Conditions and Concerns

#99

Traffic sources

Monthly visitors

Articles

Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS

2 days ago | ajmc.com | Rose McNulty

First-line luspatercept may offer significant advantages over erythropoiesis-stimulating agents (ESAs) for anemia in patients with lower-risk myelodysplastic syndromes (LR-MDS), according to a real-world study presented at the 2025 American Society of Clinical Oncology annual meeting.1The study, which evaluated interim data from an ongoing retrospective review of medical records, supports earlier clinical trial findings of luspatercept’s efficacy.
Insurance Hurdles Cause Delays and Detours in Cancer Care: Coral Omene, MD, PhD

3 days ago | ajmc.com | Laura Joszt |Coral Omene

In value-based cancer care, insurance hurdles can create administrative burdens that cause anxiety for patients and providers and delay essential treatments or divert from optimal patient care, said Coral Omene, MD, PhD, associate professor, Robert Wood Johnson Medical School. This transcript has been lightly edited; captions were auto-generated.
White House Proposes Deep Cuts to HHS in FY2026 Budget, Reducing NIH to 8 Centers

3 days ago | ajmc.com | Giuliana Grossi

The White House has proposed a sweeping reorganization and funding reduction for HHS in its fiscal year 2026 budget request, prompting alarm among public health experts, researchers, and lawmakers across the political spectrum.1,2A cornerstone of the proposal entails redirecting $14 billion toward a newly created agency—the Administration for a Healthy America—which will lead the Make America Healthy Again (MAHA) initiatives introduced by HHS Secretary Robert F.
Why ASCO Is a Must-Attend Event for Oncologists Worldwide

4 days ago | ajmc.com | Pearl Steinzor |Dirk Arnold |Vincent J. Picozzi |Danny Rischin

Oncology professionals reflect on the unique value of attending the American Society of Clinical Oncology (ASCO) annual meeting—from discovering new clinical trial results to reconnecting with peers from around the world. With major practice-changing research and global thought leadership in one place, ASCO continues to be a can't-miss event for the cancer care community.
ALL Disparities, Treatment Gaps: AYA Patients Face Unique Challenges

4 days ago | ajmc.com | Laura Joszt

For adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL), there are critical disparities in outcomes and unmet needs for later-line treatments, according to posters presented at the 2025 annual meeting of the American Society of Clinical Oncology. One poster delved into the overall survival (OS) rates by race/ethnicity, while the other evaluated the percentage of AYA patients who relapse and need treatment in the third-line setting.
FDA Launches Agency-Wide AI Tool to Aid in Scientific Review

4 days ago | ajmc.com | Rose McNulty

The FDA launched a generative artificial intelligence (AI) tool, dubbed Elsa, designed to help employees such as scientific reviewers and investigators work more efficiently, the agency announced in a press release on Monday. The tool, which was built within a high-security GovCloud environment, “modernizes agency functions and leverages AI capabilities to better serve the American people,” the release explained.
Darolutamide Gains FDA Approval for Metastatic Castration-Sensitive Prostate Cancer

4 days ago | ajmc.com | Giuliana Grossi

The FDA has approved darolutamide (Nubeqa; Bayer Healthcare Pharmaceuticals) for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC), expanding its use beyond previously approved indications.1 This approval is supported by data from the phase 3 ARANOTE trial (NCT04736199), which demonstrated a significant improvement in radiographic progression-free survival (rPFS) for patients treated with darolutamide in combination with androgen deprivation therapy (ADT)...
Managed Care Cast News Roundup: June 3, 2025

5 days ago | ajmc.com | Giuliana Grossi

HHS Secretary Robert F. Kennedy, Jr, announced that the CDC will no longer recommend routine COVID-19 vaccines for healthy children and pregnant women, a move supported by leaders of the FDA and National Institutes of Health (NIH). However, the CDC’s website still lists COVID-19 vaccination as recommended for these groups, citing studies that show vaccination during pregnancy can protect both mother and infant from severe illness.
CDC Urges All International Travelers to Be Vaccinated Against Measles

5 days ago | ajmc.com | Rose McNulty

The CDC has updated its guidance on measles vaccination for international travelers, recommending that all travelers be fully vaccinated against measles regardless of their international destinations.1While the CDC recommends all US residents receive 2 doses of a measles-containing vaccine to protect against the highly contagious virus,2 the agency previously also stressed the vaccination’s importance for those traveling to countries with outbreaks.
How Can PET Cardiac Stress Testing Prevent Invasive Procedures? Merrill Stewart, MD

5 days ago | ajmc.com | Hayden E. Klein |Merrill Stewart

Captions were auto-generated. Cardiac positron emission tomography (PET) stress testing is emerging as a more accurate tool for assessing coronary artery disease (CAD), helping to reduce the need for invasive diagnostic procedures that may offer little to no clinical benefit, especially for patients with stable disease. In an interview with The American Journal of Managed Care® (AJMC®), Merrill H.